(Q43297018)

18 November 2017

Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders (English)

1 reference

18 November 2017

Daisuke Watanabe

1

1 reference

18 November 2017

Akiyo Tanabe

2

1 reference

18 November 2017

Mitsuhide Naruse

3

1 reference

18 November 2017

Shunichi Morikawa

4

1 reference

18 November 2017

Taichi Ezaki

5

1 reference

18 November 2017

Kazue Takano

6

1 reference

18 November 2017

7 August 2009

1 reference

18 November 2017

Hypertension Research

1 reference

18 November 2017

32

1 reference

18 November 2017

9

1 reference

18 November 2017

807-815

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.106

18 November 2017

0 references

cites work

The metabolic syndrome and chronic kidney disease in U.S. adults

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

An association between body mass index and estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renal injury in the extremely obese patients with normal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

How does proteinuria cause progressive renal damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renin-angiotensin-aldosterone system and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Obesity, proteinuria and progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Glomerular hemodynamics in severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Glomerular sclerosis in patients with massive obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Obesity and target organ damage: the kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Myofibroblast phenotypes expression in experimental renal scarring

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Renal injury from angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Identifiers

DOI

10.1038/HR.2009.106

1 reference

18 November 2017

1 reference